Evolution Research Group, a clinical research site company based in New Providence, announced Wednesday it has promoted Andria Chastain to chief operating officer and hired Paul Greene as chief business officer.
Chastain, who has more than 20 years of experience in the clinical research industry, has been with ERG since its inception. She previously served as senior vice president at the company.
In her new role, she will continue to manage clinical operations and recruitment as well as aid in ERG’s mergers and acquisitions strategy.
“I am incredibly fortunate to work with so many dedicated professionals whose expertise, commitment to quality, and passion to discover better patient treatments has made us a leader in the industry. Together we will continue to seek solutions that address unmet medical needs and promote the growth of our organization,” Chastain said.
Greene joins ERG from Syneos Health. In his new role, he will be responsible for strategic growth initiatives and relationships, business development, client budgets and contracts, and marketing.
“ERG is at a key juncture in its expansion and the experience and professionalism of its experts position the company perfectly for strong growth,” Greene said. “Clinical sites are critical to the successful execution of research programs and ERG represents the best in clinical research site quality and delivery. I want to leverage that high-caliber performance for the future of ERG and the well-being of the patients we serve.”
“Andria and Paul are formidable leaders who, together with our medical, operational, compliance, and client management teams, will continue to drive the growth and expansion of the organization, while maintaining the level of service ERG has always delivered for our clients, securing our reputation as a leader in the field,” ERG CEO Lori Wright said.
